"Protect research funding: The report warns that continued progress is threatened by proposed federal cuts to cancer research and health insurance. Advances in immunotherapy are the result of decades of investment in foundational scientific research–and future breakthroughs will be impossible without the same long-term commitment. The stakes couldn’t be higher: cutting research funding now would halt progress precisely when patients need it most."